(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.54% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.3%.
Bausch & Lomb's revenue in 2026 is $5,324,000,000.On average, 17 Wall Street analysts forecast BLCO's revenue for 2026 to be $2,002,268,369,076, with the lowest BLCO revenue forecast at $1,917,977,371,020, and the highest BLCO revenue forecast at $2,066,558,113,356. On average, 17 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,119,418,569,764, with the lowest BLCO revenue forecast at $2,009,054,508,750, and the highest BLCO revenue forecast at $2,227,639,639,302.
In 2028, BLCO is forecast to generate $2,235,140,109,468 in revenue, with the lowest revenue forecast at $2,095,488,498,282 and the highest revenue forecast at $2,364,076,763,274.